SPAI:NASDAQSafe Pro Group Inc. Analysis
Data as of 2026-05-02 - not real-time
$4.50
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Safe Pro Group Inc. (SPAI) is trading at $4.50, which sits above its 20‑day SMA of $4.20 but remains below the 50‑day ($4.41) and 200‑day ($5.15) averages, signaling a short‑term bounce within a longer‑term downtrend. Technical indicators are mixed: the RSI of 55 suggests neutral momentum, while the MACD histogram is positive and the MACD line sits above the signal line, hinting at a modest bullish bias. However, the overall trend is flagged as bearish, volume has been decreasing, and the 30‑day volatility exceeds 86%, underscoring a highly erratic price pattern.
Fundamentally, the company is under pressure with a –64% max drawdown, negative operating margin of –15.7%, and zero earnings per share, resulting in a price‑to‑book of 5.27 and a price‑to‑sales of 155, both markedly above industry norms. The balance sheet shows $16.8 M in cash against modest debt of $0.64 M, but cash burn remains severe with negative operating and free cash flow. Recent material news highlights the commercial rollout of the NODE‑X AI edge processor for drone threat detection and a share‑repurchase of 400,000 shares, which modestly improves float concentration. These developments provide a potential growth catalyst, yet they must contend with the company’s ongoing profitability challenges and elevated market risk.
Fundamentally, the company is under pressure with a –64% max drawdown, negative operating margin of –15.7%, and zero earnings per share, resulting in a price‑to‑book of 5.27 and a price‑to‑sales of 155, both markedly above industry norms. The balance sheet shows $16.8 M in cash against modest debt of $0.64 M, but cash burn remains severe with negative operating and free cash flow. Recent material news highlights the commercial rollout of the NODE‑X AI edge processor for drone threat detection and a share‑repurchase of 400,000 shares, which modestly improves float concentration. These developments provide a potential growth catalyst, yet they must contend with the company’s ongoing profitability challenges and elevated market risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price hovering above 20‑day SMA but below longer‑term averages
- Decreasing volume and extreme short‑term volatility
- Mixed MACD signal with overall bearish trend
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Commercial launch of NODE‑X AI processor targeting defense and public‑safety markets
- Share‑repurchase program reducing float and signaling management confidence
- Potential upside of ~137% based on upside/downside metric
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Sustained negative earnings and cash‑burn trajectory
- High beta (2.18) and historic max drawdown of ~64% indicating price fragility
- Valuation multiples far above industry averages without earnings support
Key Metrics & Analysis
Financial Health
Revenue Growth-74.40%
ROE-132.67%
ROA-71.24%
Debt/Equity3.61
P/B Ratio5.3
Op. Cash Flow$-6216366
Free Cash Flow$-1539416
Industry P/E31.2
Technical Analysis
TrendBearish
RSI55.4
Support$3.53
Resistance$4.70
MA 20$4.20
MA 50$4.41
MA 200$5.15
MACDBullish
VolumeDecreasing
Fear & Greed Index91.09
Valuation
Target Price$10.67
Upside/Downside137.04%
GradeOvervalued
TypeBlend
Risk Assessment
Beta2.18
Volatility86.24%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.